SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001020066-08-000007
Filing Date
2008-02-13
Accepted
2008-02-13 10:43:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A genz123107.txt SC 13G/A 4927
  Complete submission text file 0001020066-08-000007.txt   7190
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37205 | Film No.: 08601534
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1101 WILSON BLVD, SUITE 2300 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1101 WILSON BLVD, SUITE 2300 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A